21 May 2009
ABCC2 SNP 4445 G>a in kidney allograft recipients
J Pazik, M Ołdak, M Puzon, E Sitarek, Z Lewandowski, R Maksym, R Płoski, J Malejczyk, M DurlikAnn Transplant 2009; 14(1): 35-35 :: ID: 880326
Abstract
Chronic kidney disease (CKD) is associated with multiple hereditary predisposing factors. Multidrug resistance associated protein (MDR2) is an efflux pump engaged in terminal excretion of endogenous and xenobiotic anions, expressed on the apical surface of proximal tubular cells. To our knowledge MDR2 SNP polymorphisms have not been identified as CKD risk factor. In a case-control study 165 kidney allograft recipients and 180 blood donors were genotyped for ABCC2 4445 G>A. Distribution of ABCC2 4445 G>A results in control group were as follow: 84% GG homozygotes, 14% GA heter-ozygotes, 1.7% AA, as in general population. In kidney allograft recipients diminished frequency of allele A was found - 94.5% of individuals carried GG, 4.9% GA, 0.6% AA (P<0.005; Fisher's Exact Test). We can only speculate whether allele A's presence is associated with diminished risk of ESRD or, on the contrary, in dialysed individuals with a burden of morbid conditions precluding kidney transplantation and at last increased risk of early allograft loss. Further studies in chronic kidney disease patients are required to evaluate our finding.
Keywords: Kidney Transplantation
In Press
Original article
Fundamental Strategies and Technical Perspectives in Bile Duct Anastomosis for Living Donor Liver Transplan...Ann Transplant In Press; DOI: 10.12659/AOT.953761
Clinical Research
Retrospective Study of Implementation and Outcomes of a Non-Cryopreserved Autologous Hematopoietic Stem Cel...Ann Transplant In Press; DOI: 10.12659/AOT.954230
Clinical Research
Prognostic Prediction in Living Donor Liver Transplantation Recipients With Complete Pathological Response ...Ann Transplant In Press; DOI: 10.12659/AOT.954574
Most Viewed Current Articles
24 Aug 2021 : Review article 21,978
Normothermic Machine Perfusion (NMP) of the Liver – Current Status and Future PerspectivesDOI :10.12659/AOT.931664
Ann Transplant 2021; 26:e931664
29 Dec 2021 : Original article 18,247
Efficacy and Safety of Tacrolimus-Based Maintenance Regimens in De Novo Kidney Transplant Recipients: A Sys...DOI :10.12659/AOT.933588
Ann Transplant 2021; 26:e933588
22 Nov 2022 : Original article 16,856
Long-Term Effects of Everolimus-Facilitated Tacrolimus Reduction in Living-Donor Liver Transplant Recipient...DOI :10.12659/AOT.937988
Ann Transplant 2022; 27:e937988
05 Apr 2022 : Original article 16,762
Impact of Statins on Hepatocellular Carcinoma Recurrence After Living-Donor Liver TransplantationDOI :10.12659/AOT.935604
Ann Transplant 2022; 27:e935604






